Ansell Future Growth

Future criteria checks 4/6

Ansell is forecast to grow earnings and revenue by 22.8% and 6.7% per annum respectively. EPS is expected to grow by 21% per annum. Return on equity is forecast to be 9.9% in 3 years.

Key information

22.8%

Earnings growth rate

21.0%

EPS growth rate

Medical Equipment earnings growth	16.2%
Revenue growth rate	6.7%
Future return on equity	9.9%
Analyst coverage	Good
Last updated	01 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

CHIA:ANN - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2027	2,080	212	236	287	11
6/30/2026	2,007	189	235	285	11
6/30/2025	1,928	134	146	213	11
6/30/2024	1,619	77	210	272	N/A
3/31/2024	1,612	90	188	256	N/A
12/31/2023	1,605	104	167	239	N/A
9/30/2023	1,630	126	140	210	N/A
6/30/2023	1,655	148	113	181	N/A
3/31/2023	1,717	147	145	213	N/A
12/31/2022	1,778	145	178	245	N/A
9/30/2022	1,865	152	166	234	N/A
6/30/2022	1,952	159	155	222	N/A
3/31/2022	2,025	188	106	176	N/A
12/31/2021	2,098	218	58	130	N/A
9/30/2021	2,063	232	74	152	N/A
6/30/2021	2,027	247	90	173	N/A
3/31/2021	1,913	222	142	222	N/A
12/31/2020	1,798	197	194	270	N/A
9/30/2020	1,706	177	210	279	N/A
6/30/2020	1,614	157	226	287	N/A
3/31/2020	1,570	147	190	246	N/A
12/31/2019	1,527	138	154	204	N/A
9/30/2019	1,513	125	149	197	N/A
6/30/2019	1,499	112	145	189	N/A
3/31/2019	1,496	112	136	181	N/A
12/31/2018	1,493	112	127	172	N/A
9/30/2018	1,491	125	118	163	N/A
6/30/2018	1,490	139	108	154	N/A
3/31/2018	1,461	135	N/A	172	N/A
12/31/2017	1,433	132	N/A	190	N/A
9/30/2017	1,404	125	N/A	203	N/A
6/30/2017	1,375	119	N/A	216	N/A
12/31/2016	1,232	121	N/A	231	N/A
9/30/2016	1,292	129	N/A	232	N/A
6/30/2016	1,353	137	N/A	232	N/A
3/31/2016	1,578	164	N/A	212	N/A
12/31/2015	1,583	169	N/A	191	N/A
9/30/2015	1,614	178	N/A	195	N/A
6/30/2015	1,645	188	N/A	200	N/A
3/31/2015	1,690	126	N/A	231	N/A
12/31/2014	1,734	64	N/A	262	N/A
9/30/2014	1,662	53	N/A	242	N/A
6/30/2014	1,590	42	N/A	221	N/A
3/31/2014	1,507	95	N/A	179	N/A
12/31/2013	1,425	148	N/A	137	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ANN's forecast earnings growth (22.8% per year) is above the savings rate (2.6%).

Earnings vs Market: ANN's earnings (22.8% per year) are forecast to grow faster than the Australian market (12.6% per year).

High Growth Earnings: ANN's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: ANN's revenue (6.7% per year) is forecast to grow faster than the Australian market (5.8% per year).

High Growth Revenue: ANN's revenue (6.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ANN's Return on Equity is forecast to be low in 3 years time (9.9%).

Ansell Future Growth

Future criteria checks 4/6

Key information

Recent future growth updates

Ansell Limited Provides Earnings Guidance for the Year 2024

Ansell Limited Provides Earnings Guidance for the Full Year Ended 30 June 2023 and Fiscal Year 2024

Ansell Limited Revises Earnings Guidance for the Fiscal Year 2022

Ansell Limited Provides Earnings Guidance for the Fiscal Year 2022

Ansell Limited Revises Financial Guidance for the Fiscal Year 2021

Recent updates

Ansell Limited Announces Zubair Javeed Intention to Resign as Chief Financial Officer

Final dividend of US$0.22 announced

Ansell Limited Announces Final Dividend for the Year Ended June 30, 2024 , Payable on September 12, 2024

New minor risk - Profit margin trend

Full year 2024 earnings released: EPS: US$0.59 (vs US$1.17 in FY 2023)

Ansell Limited (ASX:ANN) completed the acquisition of Personal Protective Equipment business of Kimberly-Clark Corporation (NYSE:KMB).

Ansell Limited to Report Fiscal Year 2025 Results on Aug 26, 2025

Ansell Limited has filed a Follow-on Equity Offering in the amount of AUD 400.000001 million.

Ansell Limited has filed a Follow-on Equity Offering in the amount of AUD 400.000001 million.

First half dividend of US$0.17 announced

First half 2024 earnings released: EPS: US$0.15 (vs US$0.51 in 1H 2023)

Ansell Limited Declares Dividend for the Six Months Ended December 31, 2023, Payable on March 14, 2024

Ansell Limited Provides Earnings Guidance for the Year 2024

Ansell Limited Declares Final Dividend for Year Ended 30 June 2023, Payable on 7 September 2023

Full year 2023 earnings released: EPS: US$1.18 (vs US$1.25 in FY 2022)

Investor sentiment deteriorates as stock falls 16%

Ansell Limited Provides Earnings Guidance for the Full Year Ended 30 June 2023 and Fiscal Year 2024

Ansell Limited to Report First Half, 2024 Results on Feb 20, 2024

Ansell Limited to Report First Half, 2024 Results on Feb 20, 2024

Now 21% undervalued after recent price drop

Ansell Limited Announces Board Changes, Effective on 24 October 2023

First half 2023 earnings released: EPS: US$0.51 (vs US$0.61 in 1H 2022)

Now 24% undervalued after recent price drop

Ansell Limited Announces Dividend for the Six Months Ended December 31, 2022, Payable on March 9, 2023

Ansell Limited Announces Appointment of Debra Goodin as an Independent Nonexecutive Director

Non-Executive Director recently bought AU$130k worth of stock

Ansell Limited to Report First Half, 2023 Results on Feb 14, 2023

Full year 2022 earnings released: EPS: US$1.25 (vs US$1.92 in FY 2021)

Ansell Limited, Annual General Meeting, Oct 26, 2023

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Ansell Limited Announces Dividend for the Period of Six Months Ended December 31, 2021, Payable on March 09, 2022

Investor sentiment deteriorated over the past week

Ansell Limited Revises Earnings Guidance for the Fiscal Year 2022

High number of new directors

Ansell Limited Provides Earnings Guidance for the Fiscal Year 2022

Full year 2021 earnings released: EPS US$1.92 (vs US$1.22 in FY 2020)

New 90-day high: AU$39.25

First half 2021 earnings released: EPS US$0.83 (vs US$0.50 in 1H 2020)

Revenue misses expectations

Ansell Limited Revises Financial Guidance for the Fiscal Year 2021

Ansell Limited (ASX:ANN) acquired life science business from Primus Gloves Private Limited and SANREA Healthcare Products Pvt Limited.

Independent Non-Executive Director recently sold AU$260k worth of stock

New 90-day low: AU$35.58

MD, CEO & Executive Director recently sold AU$3.2m worth of stock

New 90-day high: AU$42.03

New 90-day high: AU$41.05

Independent Non-Executive Director recently bought AU$55k worth of stock

Independent Non-Executive Director recently bought AU$55k worth of stock

Full year earnings released - EPS AU$1.22

Ansell Limited to Report Fiscal Year 2021 Results on Aug 24, 2021

New 90-day high - AU$40.57

New 90-day high - AU$39.20

Ansell Limited (ASX:ANN) completed the acquisition 50% stake in CAREPLUS (M) SDN. BHD from Careplus Group Berhad (KLSE:CAREPLS).

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies